Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.

Clinical trial NCT04736602 · COMPLETED

Trial details

NCT number: NCT04736602
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Central Precocious Puberty

Start date: 2021-03-27
Primary completion: 2022-02-09
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.